Skinvisible Pharmaceuticals (SKVI) is a research-and-development company that licenses its proprietary formulations made with Invisicare®, its patented polymer delivery system that offers life-cycle management and unique enhancements for topically delivered products. Skinvisible receives a combination of research and development fees, upfront license fees, and ongoing royalties for the life of the Invisicare® patent. Skinvisible's value lies in its ability to continually generate new IP (Intellectual. Property) on dermatology and medical products formulated with Invisicare®
For More Information read the January 2012 Letter to SKVI shareholders or go to http://www.skinvisible.com

You may also inquire about Skinvisible by calling Princeton Research at 702-650-3000.
Rule 17B Requirements — Disclosure of Payment for Investor Relations– Princeton Research has received 150,000 restricted shares from Skinvisible in exchange for investor relations services.

Thursday February 9, 2012 Balanced Investment Strategies-Options and Stocks To Buy - Forex - Precious Metals Analysis, Market News, Plus ; Skinvisible Pharmaceuticals CEO Terry Howlett.

IntelliCell BioSciences Inc. offers Intellicell™, a treatment for the correction of lines, wrinkles, and dermal defects, as well as for various treatments, including anti-aging, scarring, burns, and non-healing wounds; stem cell product candidates for treating aging dermal skin; and product candidates in the areas of osteoarthritis, cartilage and meniscus regeneration, and general dermal regeneration, the applications for its product are wide and diverse, IntelliCell BioSciences, Inc. is based in New York, New York.

IntelliCell intends to initially focus on selling laboratory suites and licensing its technology to doctors for use in their offices for their patients. The company is also setting up Centers of Excellence where doctors can treat their patients.For additional information, visit http://www.intellicellbiosciences.com or call Princeton Research at
702-650-3000 Rule 17B Requirements — Disclosure of Payment for Investor Relations– Princeton Research has contracted to receive 10,000 restricted shares from IntelliCell BioSciences for investor relations.

Tuesday February 7, 2012 Balanced Investment Strategies-Options and Stocks To Buy - Forex - Precious Metals Analysis, Market News, Plus ; IntelliCell BioSciences Inc

IntelliCell BioSciences Inc., http://www.intellicellbiosciences.com (symbol SVFC) is a pioneering regenerative medicine company focused on the expanding regenerative medical markets. IntelliCell BioSciences develops a portfolio of products and services that targets a wide and diverse regenerative, preventative, and curative medical market including age related disease states to sports related injuries.

IntelliCell BioSciences Inc. offers Intellicell™, a treatment for the correction of lines, wrinkles, and dermal defects, as well as for various treatments, including anti-aging, scarring, burns, and non-healing wounds; stem cell product candidates for treating aging dermal skin; and product candidates in the areas of osteoarthritis, cartilage and meniscus regeneration, and general dermal regeneration, the applications for its product are wide and diverse, IntelliCell BioSciences, Inc. is based in New York, New York.

IntelliCell intends to initially focus on selling laboratory suites and licensing its technology to doctors for use in their offices for their patients. The company is also setting up Centers of Excellence where doctors can treat their patients. IntelliCell announced last month it licensed its proprietary, patent pending technology to RegenaStem Inc., a Canadian Federally Incorporated Company, with offices in Ontario, The license calls for investing a minimum of $500,000 to a maximum of $1.5 million into IntelliCell BioSciences and paying royalties of 30% of net revenue.

For additional information, visit http://www.intellicellbiosciences.com or call Princeton Research at 702-650-3000

*Rule 17B Requirements — Disclosure of Payment for Investor Relations– Princeton Research has contracted to receive 10,000 restricted shares from IntelliCell BioSciences to do investor relations.

Thursday February 2, 2012 Balanced Investment Strategies-Options and Stocks To Buy - Forex - Precious Metals Analysis, Market News, Plus ; Dr. Steven Victor, CEO IntelliCell BioSciences Inc

IntelliCell BioSciences Inc., http://www.intellicellbiosciences.com (symbol SVFC) is a pioneering regenerative medicine company focused on the expanding regenerative medical markets. IntelliCell BioSciences develops a portfolio of products and services that targets a wide and diverse regenerative, preventative, and curative medical market including age related disease states to sports related injuries.

Dr. Steven Victor is renowned in the field of Dermatology, pioneering some of the most effective and interesting treatments in skin rejuvenation today. He has lectured around the world, consulted for numerous cosmetic companies, been featured in numerous magazines and various television and news segments. Dr. Victor has developed numerous successful consumer products for distribution through the Cosmeceuticals and Prescription skin care channels. Medicis (MRX/NYSE), a specialty pharmaceutical company that develops and markets products for the treatment of dermatological, aesthetic, and podiatric conditions, was initially launched successfully with 6 Rx products of Dr. Victor’s including Benzashave, a patented product. Dr. Victor launched one of the first acne infomercials in 1992 and developed the products for the Cher Skin Care infomercial. Dr. Victor has held numerous teaching appointments and holds a Bachelor of Arts degree from New York University and received his M.D. degree from New York College.

Lucas Energy. LEI http://www.lucasenergy.com is an Independent oil & gas company with oil properties in the Austin Chalk and Eagle Ford Shale. Lucas has shown steady improvement over the past 3 years, has little or no debt and has plans to increase its production by 50 % for the 2012 to 2013 period from its more than 27,000 gross acres, ncluded in that figure are 9000 acres in the Eagleford Shale/ Eaglebine trends.Just last week Lucas commenced drilling a well from an old horizontal well in the Austin Chalk formation, the well is being drilled with joint venture partners. The well is on the same lease as the two Hilcorp Oil Company drilled that Marathon Oil operates in the Eagle Ford formation. While Lucas Energy‘s business plan in part is to; acquire wells at low cost, develop the underlying potential of leases by improving production in the wells, and working with joint venture partners, this month it has retained Global Hunter Securities and Knight Capital to advise the Company in selling certain properties in the Eaglebine and Eagle Ford trend in Texas. Lucas Energy anticipates soliciting bids for the properties and hopes to close on a transaction in the next three months. Each of these areas has seen similar transactions closed in 2011, and it’s likely that 2012 will see similar transactions especially with elevated oil prices and a stable economy.

Tuesday January 31 2012 Balanced Investment Strategies-Options and Stocks To Buy - Forex - Precious Metals Analysis, Market News, Plus William Sawyer, CEO of Lucas Energy (LEI)

 Sampling of Exceptional Shows with
The Bill Chippas Show Market Predictions

Thursday Jan 19- Special Guest : Oscar Carboni
from Livewithoscar.com http://www.livewithoscar.com .
Plus Balanced Investment Strategies-Options and Stocks To Buy
Forex - Precious Metals Analysis and Market News.

Hecla ( HL) is the largest silver producer in the U.S. and was established as a company in 1891, which makes Hecla Mining the oldest precious metals mining company in North America. Hecla Mining produces silver from Lucky Friday mine in Idaho and Greens Creek mine in Alaska. Yesterday the Mine Safety and Health Administration ("MSHA") ordered the silver shaft at the Lucky Friday mine closed for removal of built-up material in the shaft. The silver shaft is a one-mile deep shaft from the surface and the primary access to the Lucky Friday mine. This order was pursuant to the investigation following the December 14, 2011 rock burst. Hecla's 2012 silver production is now estimated to be approximately 7 million ounces. Previous estimate of the production was 9.5 million ounces. We think a buying opportunity on bad news for a well-established US Producer of precious metals has arrived. Mr. Baker will give and update on the situation and steps being taken at Hecla Mining to resume production. 

Thursday January 12 2012; Special Guests; Hecla Mining CEO
Phil Baker provided a company update. Please Listen or View the Show. Also Joining us was Tim Connolly Entrepreneur and Radio Talk Show Host to speak about a new business venture to help train workers for employment in the US Oil Patch. for more information about a Job in the USA Oil Patch listen to the show , email resume to info@tgnrg.com or visit Bill's Blog .

                 Bill's Market Musings Blog ,click to enter Blogsite

 

      Sampling of Exceptional Shows with
The Bill Chippas Show Market Predictions